This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Ultrasound-guided Supraclavicular Brachial Plexus Blockade

This study has been terminated.
(Clinical volume of patients for recruitment stopped.)
Sponsor:
Information provided by (Responsible Party):
University of Manitoba
ClinicalTrials.gov Identifier:
NCT00523055
First received: August 28, 2007
Last updated: May 9, 2017
Last verified: April 2011
  Purpose
Pain Clinic patients undergoing physiotherapy for rehabilitation often have arm freezing performed. The quality of physiotherapy is felt to be superior with good pain control. The quality of the freezing is felt to be better when it is done with ultrasound guidance. We are able to use less drug to achieve the same result. For this reason, we are doing a study to look at the level of freezing drug that accumulates in the body. We feel that the drug levels will be significantly different. We also feel that the time-to-peak drug level will be different than with traditional arm freezing procedures.

Condition Intervention
Pain Drug: Lidocaine

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Basic Science
Official Title: Ultrasound-guided Supraclavicular Brachial Plexus Blockade: A Pharmacokinetic Study of Lidocaine and Adrenaline

Resource links provided by NLM:


Further study details as provided by University of Manitoba:

Primary Outcome Measures:
  • Lidocaine drug level [ Time Frame: 40 minutes ]

Secondary Outcome Measures:
  • brachial plexus block quality [ Time Frame: 30 minutes ]
  • Physiotherapy quality [ Time Frame: within 2 hours ]

Enrollment: 10
Study Start Date: May 2008
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Lidocaine
    Lidocaine, 5 mg/kg, via needle placed adjacent to brachial plexus with ultrasound, dosing separated by 1 week, 2 doses in total, one block will contain 5 mcg/kg of adrenaline
  Eligibility

Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients undergoing brachial plexus anesthesia as part of disease management who have consented to participate in the study

Exclusion Criteria:

  • Contraindication to brachial plexus anesthesia
  • Informed consent not obtained
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00523055

Locations
Canada, Manitoba
Health Sciences Pain Management Centre
Winnipeg, Manitoba, Canada, R3P1S4
Sponsors and Collaborators
University of Manitoba
Investigators
Principal Investigator: Eric N Sutherland, MD University of Manitoba
  More Information

Publications:
Responsible Party: University of Manitoba
ClinicalTrials.gov Identifier: NCT00523055     History of Changes
Other Study ID Numbers: B2007:078
Study First Received: August 28, 2007
Last Updated: May 9, 2017

Keywords provided by University of Manitoba:
Pain
Brachial Plexus Anesthesia
Plasma Lidocaine Levels
Ultrasound

Additional relevant MeSH terms:
Lidocaine
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Anti-Arrhythmia Agents
Voltage-Gated Sodium Channel Blockers
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on August 18, 2017